Symmetry Partners’s Texas Instruments TXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,570
Closed -$1.08M 473
2024
Q2
$1.08M Sell
5,570
-398
-7% -$73.5K 0.06% 148
2024
Q1
$1.04M Hold
5,968
0.08% 169
2023
Q4
$1.02M Sell
5,968
-2,078
-26% -$322K 0.06% 158
2023
Q3
$1.28M Hold
8,046
0.07% 145
2023
Q2
$1.45M Sell
8,046
-2,164
-21% -$373K 0.08% 135
2023
Q1
$1.9M Hold
10,210
0.1% 107
2022
Q4
$1.69M Hold
10,210
0.1% 111
2022
Q3
$1.58M Hold
10,210
0.11% 104
2022
Q2
$1.57M Hold
10,210
0.11% 102
2022
Q1
$1.87M Hold
10,210
0.12% 100
2021
Q4
$1.92M Sell
10,210
-49
-0.5% -$9.41K 0.12% 108
2021
Q3
$1.99M Hold
10,259
0.13% 103
2021
Q2
$1.97M Sell
10,259
-1,450
-12% -$272K 0.13% 100
2021
Q1
$2.21M Sell
11,709
-1,604
-12% -$279K 0.16% 83
2020
Q4
$2.19M Buy
13,313
+438
+3% +$68.1K 0.17% 81
2020
Q3
$1.84M Buy
12,875
+11,183
+661% +$1.52M 0.16% 85
2020
Q2
$215K Buy
+1,692
New +$197K 0.03% 282
2020
Q1
Sell
-10,543
Closed -$1.35M 357
2019
Q4
$1.35M Buy
10,543
+8,720
+478% +$1.08M 0.28% 46
2019
Q3
$236K Buy
+1,823
New +$225K 0.05% 295

Other funds holding TXN

Symmetry Partners's TXN Position: Q3 2024 in Review

Symmetry Partners sold out of Texas Instruments (TXN) in Q3 2024, closing a stake of 5,570 shares — an estimated $1.08M sold.

Symmetry Partners first reported a position in TXN in Q3 2019 and held it in 19 quarters. The position peaked at $2.21M in Q1 2021. 2,278 funds tracked by Wall St. Rank hold TXN as of Q3 2024.

  • Symmetry Partners reported no remaining Texas Instruments position as of Q3 2024 after selling out during the quarter.
  • Symmetry Partners sold 5,570 Texas Instruments shares in Q3 2024, an estimated $1.08M.
  • Symmetry Partners first reported a position in Texas Instruments in Q3 2019 and held it in 19 quarters.
  • Symmetry Partners's Texas Instruments position peaked at $2.21M in Q1 2021.
  • 2,278 funds tracked by Wall St. Rank held Texas Instruments as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.